These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28626170)

  • 21. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
    Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
    Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.
    Bergenstal RM; Strock E; Mazze R; Powers MA; Monk AM; Richter S; Souhami E; Ahrén B
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.
    Takeishi S; Tsuboi H; Takekoshi S
    J Diabetes Investig; 2018 Jan; 9(1):91-99. PubMed ID: 28371461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device.
    Manuel-y-Keenoy B; Vertommen J; Abrams P; Van Gaal L; De Leeuw I; Messeri D; Poscia A
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S24-31. PubMed ID: 15551295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution of post-breakfast plasma glucose to the glycemic control of type 2 diabetic patients].
    Sartori MS; Aragon FF; Padovani CR; Pimenta Wde P
    Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):53-9. PubMed ID: 16628275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skipping breakfast is associated with glycemic variability in patients with type 2 diabetes.
    Hashimoto Y; Kaji A; Sakai R; Osaka T; Ushigome E; Hamaguchi M; Yamazaki M; Fukui M
    Nutrition; 2020 Mar; 71():110639. PubMed ID: 31869658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
    Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
    Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
    Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
    Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes.
    Ohara M; Fukui T; Ouchi M; Watanabe K; Suzuki T; Yamamoto S; Yamamoto T; Hayashi T; Oba K; Hirano T
    Diabetes Res Clin Pract; 2016 Dec; 122():62-70. PubMed ID: 27810687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of moderate exercise for 30 min at 30 min versus 60 min after dinner on glycemic control in patients with type 2 diabetes: a randomized, crossover, self-controlled study].
    Li Z; Hu Y; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1165-1170. PubMed ID: 30377118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Starting insulin therapy with basal insulin analog or premix insulin analog in T2DM: a pooled analysis of treat-to-target trials.
    Fonseca V; Davidson J; Home P; Snyder J; Jellinger P; Dyhr Toft A; Barnett A
    Curr Med Res Opin; 2010 Jul; 26(7):1621-8. PubMed ID: 20429817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA
    Færch K; Alssema M; Mela DJ; Borg R; Vistisen D
    Nutr Diabetes; 2018 Jun; 8(1):38. PubMed ID: 29855488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes.
    Terada T; Wilson BJ; Myette-Côté E; Kuzik N; Bell GJ; McCargar LJ; Boulé NG
    Metabolism; 2016 May; 65(5):599-608. PubMed ID: 27085769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.